|
1
|
Di Pietro M, Filardo S, De Santis F,
Mastromarino P and Sessa R: Chlamydia pneumoniae and oxidative
stress in cardiovascular disease: State of the art and prevention
strategies. Int J Mol Sci. 16:724–735. 2014. View Article : Google Scholar
|
|
2
|
Endemann DH and Schiffrin EL: Endothelial
dysfunction. J Am Soc Nephrol. 15:1983–1992. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guo J, Li L, Wu YJ, et al: Inhibitory
effects of Brazilin on the vascular smooth muscle cell
proliferation and migration induced by PDGF-BB. Am J Chin Med.
41:1283–1296. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Michael AF, Blau E and Vernier RL:
Glomerular polyanion. Alteration in aminonucleoside nephrosis. Lab
Invest. 23:649–657. 1970.PubMed/NCBI
|
|
5
|
Hara M, Yanagihara T, Takada T, et al:
Podocalyxin on the glomerular epithelial cells is preserved well in
various glomerular diseases. Nephron. 67:123–124. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Somasiri A, Nielsen JS, Makretsov N, et
al: Overexpression of the anti-adhesin podocalyxin is an
independent predictor of breast cancer progression. Cancer Res.
64:5068–5073. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Larrucea S, Butta N, Rodriguez RB, et al:
Podocalyxin enhances the adherence of cells to platelets. Cell Mol
Life Sci. 64:2965–2974. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cipollone JA, Graves ML, Köbel M, et al:
The anti-adhesive mucin podocalyxin may help initiate the
transperitoneal metastasis of high grade serous ovarian carcinoma.
Clin Exp Metastasis. 29:239–252. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fernández D, Horrillo A, Alquezar C,
González-Manchón C, Parrilla R and Ayuso MS: Control of cell
adhesion and migration by podocalyxin. Implication of Rac1 and
Cdc42. Biochem Biophys Res Commun. 432:302–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin CW, Sun MS and Wu HC: Podocalyxin-like
1 is associated with tumor aggressiveness and metastatic gene
expression in human oral squamous cell carcinoma. Int J Oncol.
45:710–718. 2014.PubMed/NCBI
|
|
11
|
Huang BS, Luo QZ, Han Y, Li XB, Cao LJ and
Wu LX: microRNA-223 promotes the growth and invasion of
glioblastoma cells by targeting tumor suppressor PAX6. Oncol Rep.
30:2263–2269. 2013.PubMed/NCBI
|
|
12
|
Chen KC, Hsieh IC, Hsi E, et al: Negative
feedback regulation between microRNA let-7g and the oxLDL receptor
LOX-1. J Cell Sci. 124:4115–4124. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang M, Li W, Chang GQ, et al: MicroRNA-21
regulates vascular smooth muscle cell function via targeting
tropomyosin 1 in arteriosclerosis obliterans of lower extremities.
Arterioscler Thromb Vasc Biol. 31:2044–2053. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Goettsch C, Rauner M, Pacyna N, Hempel U,
Bornstein SR and Hofbauer LC: miR-125b regulates calcification of
vascular smooth muscle cells. Am J Pathol. 179:1594–1600. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Arocho A, Chen B, Ladanyi M and Pan Q:
Validation of the 2-DeltaDeltaCt calculation as an alternate method
of data analysis for quantitative PCR of BCR-ABL P210 transcripts.
Diagn Mol Pathol. 15:56–61. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sizemore S, Cicek M, Sizemore N, et al:
Podocalyxin increases the aggressive phenotype of breast and
prostate cancer cells in vitro through its interaction with ezrin.
Cancer Res. 67:6183–6191. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu H, Yang L, Liao D, Chen Y, Wang W and
Fang J: Podocalyxin regulates astrocytoma cell invasion and
survival against temozolomide. Exp Ther Med. 5:1025–1029.
2013.PubMed/NCBI
|
|
18
|
Sassetti C, Tangemann K, Singer MS,
Kershaw DB and Rosen SD: Identification of podocalyxin-like protein
as a high endothelial venule ligand for L-selectin: parallels to
CD34. J Exp Med. 187:1965–1975. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ghosh G, Subramanian IV, Adhikari N, et
al: Hypoxia-induced microRNA-424 expression in human endothelial
cells regulates HIF-α isoforms and promotes angiogenesis. J Clin
Invest. 120:4141–4154. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kuhnert F and Kuo CJ: miR-17-92
angiogenesis micromanagement. Blood. 115:4631–4633. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Staszel T, Zapala B, Polus A, et al: Role
of microRNAs in endothelial cell pathophysiology. Pol Arch Med
Wewn. 121:361–366. 2011.PubMed/NCBI
|
|
22
|
Wu C, Gong Y, Yuan J, et al: microRNA-181a
represses ox-LDL-stimulated inflammatory response in dendritic cell
by targeting c-Fos. J Lipid Res. 53:2355–2363. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li D and Mehta JL: Antisense to LOX-1
inhibits oxidized LDL-mediated upregulation of monocyte
chemoattractant protein-1 and monocyte adhesion to human coronary
artery endothelial cells. Circulation. 101:2889–2895. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou M, Liu Z, Zhao Y, et al:
MicroRNA-125b confers the resistance of breast cancer cells to
paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist
killer 1 (Bak1) expression. J Biol Chem. 285:21496–21507. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mizuno Y, Yagi K, Tokuzawa Y, et al:
miR-125b inhibits osteoblastic differentiation by down-regulation
of cell proliferation. Biochem Biophys Res Commun. 368:267–272.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Williams KJ and Tabas I: Atherosclerosis
and inflammation. Science. 297:521–522. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cushing SD, Berliner JA, Valente AJ, et
al: Minimially modified low density lipoprotein induces monocyte
chemotactic protein 1 in human endothelial cells and smooth muscle
cells. Proc Natl Acad Sci USA. 87:5134–5138. 1990. View Article : Google Scholar
|
|
28
|
Rose CE Jr, Sung SS and Fu SM: Significant
involvement of CCL2 (MCP-1) in inflammatory disorders of the lung.
Microcirculation. 10:273–288. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Villeneuve LM, Kato M, Reddy MA, Wang M,
Lanting L and Natarjan R: Enchanced levels of microRNA-125b in
vascular smooth muscle cells of diabetic db/db mice lead to
increased inflammatory gene expression by targeting the histone
methyltransferase Suv39h1. Diabetes. 59:2904–2915. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
de Swiniarski R, Beatty D, Donoghue E, et
al: Comparison of Schrodinger and Dirac coupled-channels analyses
of the 28Si(p,p’)28Si reaction at 500 MeV. Phys Rev C Nucl Phys.
42:1137–1140. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nigam V, Sievers HH, Jensen BC, et al:
Altered microRNAs in bicuspid aortic valve: a comparison between
stenotic and insufficient valves. J Heart Valve Dis. 19:459–465.
2010.PubMed/NCBI
|
|
32
|
Ji R, Cheng Y, Yue J, et al: MicroRNA
expression signature and antisense-mediated depletion reveal an
essential role of MicroRNA in vascular neointimal lesion formation.
Circ Res. 100:1579–1588. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tili E, Michaille JJ, Cimino A, et al:
Modulation of miR-155 and miR-125b levels following
lipopolysaccharide/TNF-α stimulation and their possible roles in
regulating the response to endotoxin shock. J Immunol.
179:5082–5089. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yu J, Li Y, Li M, Qu Z and Ruan Q:
Oxidized low density lipoprotein-induced transdifferentiation of
bone marrow-derived smooth muscle-like cells into foam-like cells
in vitro. Int J Exp Pathol. 91:24–33. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Feng Y, Cai ZR, Tang Y, et al: TLR4/NF-κB
signaling pathway-mediated and oxLDL-induced up-regulation of
LOX-1, MCP-1, and VCAM-1 expressions in human umbilical vein
endothelial cells. Genet Mol Res. 13:680–695. 2014. View Article : Google Scholar : PubMed/NCBI
|
